{"database": "openregs", "table": "documents", "rows": [["FDA-2016-D-4308-0026", "FDA", "FDA-2016-D-4308", "04 Reference 3 Compliance Program Guidance Manual Chapter 42 Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:36:48Z", null, 0, 0, "09000064839beb23"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-D-4308-0026"], "units": {}, "query_ms": 11.508788913488388, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}